Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Chemotherapy vs Observation in Early-Stage Endometrial Cancer
NCT01244789Phase 2Active, not recruiting
- Sponsor
- Danish Gynecological Cancer Group
- Start
- Dec 2011
- Primary completion
- Jul 2028
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of carboplatin and Paclitaxel Micelles for Injection in endometrial cancer (EC) (2 arms), sponsored by Danish Gynecological Cancer Group. Primary endpoint: Overall survival at 1 year. Started Dec 2011; status: active, not recruiting.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01244789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244789.